Your browser doesn't support javascript.
loading
A dual diffusion model enables 3D molecule generation and lead optimization based on target pockets.
Huang, Lei; Xu, Tingyang; Yu, Yang; Zhao, Peilin; Chen, Xingjian; Han, Jing; Xie, Zhi; Li, Hailong; Zhong, Wenge; Wong, Ka-Chun; Zhang, Hengtong.
Afiliação
  • Huang L; City University of Hong Kong, Hong Kong, SAR, China.
  • Xu T; Tencent AI Lab, Shenzhen, China.
  • Yu Y; Tencent AI Lab, Shenzhen, China.
  • Zhao P; Tencent AI Lab, Shenzhen, China.
  • Chen X; Tencent AI Lab, Shenzhen, China.
  • Han J; Harvard Medical School, Boston, USA.
  • Xie Z; Regor Therapeutics Group, Shanghai, China.
  • Li H; Regor Therapeutics Group, Shanghai, China.
  • Zhong W; Regor Therapeutics Group, Shanghai, China. hailong.li@qlregor.com.
  • Wong KC; Regor Therapeutics Group, Shanghai, China.
  • Zhang H; City University of Hong Kong, Hong Kong, SAR, China. kc.w@cityu.edu.hk.
Nat Commun ; 15(1): 2657, 2024 Mar 26.
Article em En | MEDLINE | ID: mdl-38531837
ABSTRACT
Structure-based generative chemistry is essential in computer-aided drug discovery by exploring a vast chemical space to design ligands with high binding affinity for targets. However, traditional in silico methods are limited by computational inefficiency, while machine learning approaches face bottlenecks due to auto-regressive sampling. To address these concerns, we have developed a conditional deep generative model, PMDM, for 3D molecule generation fitting specified targets. PMDM consists of a conditional equivariant diffusion model with both local and global molecular dynamics, enabling PMDM to consider the conditioned protein information to generate molecules efficiently. The comprehensive experiments indicate that PMDM outperforms baseline models across multiple evaluation metrics. To evaluate the applications of PMDM under real drug design scenarios, we conduct lead compound optimization for SARS-CoV-2 main protease (Mpro) and Cyclin-dependent Kinase 2 (CDK2), respectively. The selected lead optimization molecules are synthesized and evaluated for their in-vitro activities against CDK2, displaying improved CDK2 activity.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Anti-HIV / Metacrilatos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Anti-HIV / Metacrilatos Idioma: En Ano de publicação: 2024 Tipo de documento: Article